Harker Zhang Neg
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Contact | Finals | Contact | Contact |
|
| ||
| Milpitas | 4 | Nova 42 JH | Doron Darnov |
|
|
| |
| Milpitas | 5 | St Francis TK | Jomi Epoyun |
|
|
| |
| Mlipitas | 2 | Leland AA | Sarah Youngquist |
|
|
| |
| St Marks | 2 | Bishops SR | John Sims |
|
|
| |
| St Marks | 4 | Lexington AK | Colton Gilbert |
|
|
| |
| St Marks | 5 | Westwood AP | Annabelle Long |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Milpitas | 4 | Opponent: Nova 42 JH | Judge: Doron Darnov 1AC - COVID insulin |
| Milpitas | 5 | Opponent: St Francis TK | Judge: Jomi Epoyun 1AC - pandemic response innovation |
| Mlipitas | 2 | Opponent: Leland AA | Judge: Sarah Youngquist 1AC - trad ( |
| St Marks | 2 | Opponent: Bishops SR | Judge: John Sims 1AC - cap |
| St Marks | 4 | Opponent: Lexington AK | Judge: Colton Gilbert 1AC - vax ineq indopak |
| St Marks | 5 | Opponent: Westwood AP | Judge: Annabelle Long 1AC - whole res w evergreening adv |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
00 - Contact InformationTournament: Contact | Round: Finals | Opponent: Contact | Judge: Contact | 9/24/21 |
SO - CP EvergreeningTournament: St Marks | Round: 5 | Opponent: Westwood AP | Judge: Annabelle Long CPTEXT: The member nations of the World Trade Organization ought toincrease penalties for patent abuse and evergreening fraud in the pharmaceutical industry.====Evergreening links to politics and collapses innovation, BUT the downsides are empirically debunked media hype – shifting enforcement for existing patent law solves abuse without harming pharma==== CP solves the aff while fostering innovation – directly comparative to the affHolman 20 ~Christopher, Professor of Law, University of Missouri-Kansas City School of Law. "Congress Should Decline Ill-Advised Legislative Proposals Aimed at Evergreening of Pharmaceutical Patent Protection" p. 29-30 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3593954~~ | 10/17/21 |
SO - CP IndiaTournament: St Marks | Round: 4 | Opponent: Lexington AK | Judge: Colton Gilbert CPText: The United States should:ramp up domestic manufacturing of the Covid vaccine and donate them to Indiaprovide financial incentives to domestic pharmaceutical companies to facilitate Indian manufacturing through tech transfer | 10/17/21 |
SO - CT EvergreeningTournament: St Marks | Round: 5 | Opponent: Westwood AP | Judge: Annabelle Long Vague standards for new patents are unenforceable and explode costs – the link alone turns case because the plan is unenforceableMadigan and O'Connor 19 ~Kevin Madigan joined CPIP in January of 2016. As Deputy Director, Kevin works closely with CPIP scholars in their research and promotion of comprehensive intellectual property law and policy. Before joining CPIP, Kevin worked as an intellectual property Research Associate at Finnegan Henderson Farabow Garrett and Dunner and also interned at the Recording Industry Association of America. Sean O'Connor, noted innovation law scholar, is a Professor of Law and Faculty Director of the Center for Intellectual Property x Innovation Policy (C-IP2) at George Mason University, Antonin Scalia Law School. ""No Combination Drug Patents Act" Stalls, but Threats to Innovation Remain." https://cip2.gmu.edu/2019/06/27/no-combination-drug-patents-act-stalls-but-threats-to-innovation-remain/~~ Eliminating evergreening ends the pharmaceutical industry – incremental developments are key to global breakthroughs on emerging pathogensMadigan and O'Connor 19 ~Kevin Madigan joined CPIP in January of 2016. As Deputy Director, Kevin works closely with CPIP scholars in their research and promotion of comprehensive intellectual property law and policy. Before joining CPIP, Kevin worked as an intellectual property Research Associate at Finnegan Henderson Farabow Garrett and Dunner and also interned at the Recording Industry Association of America. Sean O'Connor, noted innovation law scholar, is a Professor of Law and Faculty Director of the Center for Intellectual Property x Innovation Policy (C-IP2) at George Mason University, Antonin Scalia Law School. ""No Combination Drug Patents Act" Stalls, but Threats to Innovation Remain." https://cip2.gmu.edu/2019/06/27/no-combination-drug-patents-act-stalls-but-threats-to-innovation-remain/~~ It tips the entire industry into insolvencyGloberman and Lybecker 14 ~Steven Globerman is Resident Scholar and Addington Chair in Measurement at the Fraser Institute as well as Professor Emeritus at Western Washington University. Kristina M.L. Acri, née Lybecker – Chair of the Department of Economics and Business, Colorado College. "The Benefits of Incremental Innovation FOCUS ON THE PHARMACEUTICAL INDUSTRY The Benefits of Incremental Innovation FOCUS ON THE PHARMACEUTICAL INDUSTRY." https://www.fraserinstitute.org/sites/default/files/benefits-of-incremental-innovation.pdf~~ Weakening IP encourages imitation, not innovation – it removes the financial incentive to inventGloberman and Lybecker 14 ~Steven Globerman is Resident Scholar and Addington Chair in Measurement at the Fraser Institute as well as Professor Emeritus at Western Washington University. Kristina M.L. Acri, née Lybecker – Chair of the Department of Economics and Business, Colorado College. "The Benefits of Incremental Innovation FOCUS ON THE PHARMACEUTICAL INDUSTRY The Benefits of Incremental Innovation FOCUS ON THE PHARMACEUTICAL INDUSTRY." https://www.fraserinstitute.org/sites/default/files/benefits-of-incremental-innovation.pdf~~ | 10/17/21 |
SO - DA ChinaTournament: Milpitas | Round: 4 | Opponent: Nova 42 JH | Judge: Doron Darnov DA – ChinaThe US still leads the world in pharmaceutical innovation, but China's catching up – to keep the advantage, we need to maintain our strong IP frameworkEzell 20 – Ezell, Stephen, 16 July 2020, "Ensuring U.S. Biopharmaceutical Competitiveness," Information Technology and Innovation Foundation, https://itif.org/publications/2020/07/16/ensuring-us-biopharmaceutical-competitiveness Stephen Ezell is vice president, global innovation policy, at the Information Technology and Innovation Foundation (ITIF). He focuses on science and technology policy, international competitiveness, trade, manufacturing, and services issues. Ezell holds a B.S. from the School of Foreign Service at Georgetown University, with an honors certificate from Georgetown's Landegger International Business Diplomacy program. ~Harker KB~ Reducing IP rights guts US pharmaceutical innovation and leadership – profit incentive is key to undertaking the risks.James M. Roberts, PhD Candidate, 21 ~PhD Candidate in Public Policy @ VA Tech, MA International and Development Economics from Yale, MA Business Administration from the University of Pittsburgh, Research Fellow For Economic Freedom and Growth @ Heritage~, "Biden's OK of Global Theft of America's Intellectual Property Is Wrong, Dangerous," Heritage Foundation, 6-25-2021, https://www.heritage.org/public-health/commentary/bidens-ok-global-theft-americas-intellectual-property-wrong-dangerous C.VC Chinese biotech leadership risks planetary catastrophe – lack of ethical and legal regulations increases the possibility of bioweapon attacks and other security threats.Scott Moore, PhD, 19 ~PhD Politics from Oxford, Director of China Programs and Strategic Initiatives @ Penn~, "China's Biotech Boom Could Transform Lives—or Destroy Them," Foreign Policy, 11-8-2019, https://foreignpolicy.com/2019/11/08/cloning-crispr-he-jiankui-china-biotech-boom-could-transform-lives-destroy-them/ C.VC Weaponized biology is an existential threat.Hamish De Bretton-Gordon, CBRN Expert @ British Army, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ C.VC | 9/25/21 |
SO - DA Climate PatentsTournament: St Marks | Round: 2 | Opponent: Bishops SR | Judge: John Sims DA -Climate Patents====Climate innovation is high and solving warming, but continued investment is key — reducing IP collapses collaboration and investments.==== Only a strong private sector can solve climate changeGulker 19 ~Max Gulker, 2-11-2019, "How a Strong Private Sector Will Address Climate Change," AIER, https://www.aier.org/article/how-a-strong-private-sector-will-address-climate-change/~~ Climate change is existential and emerging technology is keyEspinosa 20 ~Patricia Espinosa 04-xx-2020Frontier technologies to protect the environment and tackle climate change https://www.itu.int/en/action/environment-and-climate-change/Documents/frontier-technologies-to-protect-the-environment-and-tackle-climate-change.pdf~~ Warming causes extinctionKlein 14~(Naomi Klein, award-winning journalist, syndicated columnist, former Miliband Fellow at the London School of Economics, member of the board of directors of 350.org), This Changes Everything: Capitalism vs. the Climate, pp. 12-14~ | 10/16/21 |
SO - DA InnovationTournament: Mlipitas | Round: 2 | Opponent: Leland AA | Judge: Sarah Youngquist DA – InnovationPharmaceutical innovation is accelerating now – new medicines are substantially better than existing treatments.Wills, MBA, and Lipkus, PhD, 20 – Todd J. Wills ~Managing Director @ Chemical Abstracts Service, MBA from THE Ohio State University~ and Alan H. Lipkus ~Senior Data Analyst @ Chemical Abstracts Service, PhD Physical Chemistry from the University of Rochester~, "Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation," ACS Medicinal Chemistry Letters, Vol. 11, 2020, https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00319 C.VC The biopharmaceutical industry is uniquely reliant on IP protections – undermining them would kill innovation by making an already expensive process completely unfeasible.Kristina M. Lybecker, PhD, 17 ~PhD Economics, Associate Professor of Economics @ Colorado College~, "Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up," Fraser Institute, January 2017, https://www.fraserinstitute.org/sites/default/files/intellectual-property-rights-protection-and-the20biopharmaceutical-industry.pdf C.VC Pharmaceutical innovation is key to protecting against future pandemics, bioterrorism, and antibiotic resistance.Marjanovic and Fejiao '20 Marjanovic, Sonja, and Carolina Feijao. Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020). ~Quality Control~ Bioterrorism and future pandemics cause extinction.Hamish De Bretton-Gordon, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ C.VC | 9/25/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
9/25/21 | 23vincentz@studentsharkerorg |
| |
9/25/21 | 23vincentz@studentsharkerorg |
| |
9/25/21 | 23vincentz@studentsharkerorg |
| |
10/16/21 | 23vincentz@studentsharkerorg |
| |
10/17/21 | 23vincentz@studentsharkerorg |
|